Delivery Order SPE2DB25D3020-SPE2DB25FWHHZ
- Not listed
- The Defense Logistics Agency awarded a $1,593.58 delivery order to AmerisourceBergen Drug Corp for VEOZAH 45 mg tablets (30-count) under a firm fixed-price contract with an ultimate completion date of July 24, 2025. This non-competitive, non-set-aside award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The pharmaceutical distributor,...
- AmerisourceBergen Drug Corp received a delivery order award from the Defense Logistics Agency (DLA) on September 17, 2025, for VEOZAH 45 mg tablets (30-count units) with a ceiling value of $2,227.38 under a firm fixed-price contract structure. This delivery order represents a competitive award with no set-aside designation, issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $3,715.38 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count) on September 8, 2025, with completion targeted for September 9, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and specifies performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's existing Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,254.01 for Veozah 45 mg tablets (30-count units) on September 10, 2025, with completion scheduled for September 11, 2025. This firm fixed-price contract represents a non-competitive set-aside procurement for pharmaceutical supply to support federal medical needs. The award was fulfilled by AmerisourceBergen's Corporate Office division, with performance conducted at the company's Conshohocken,...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,921.89 by the Defense Logistics Agency (DLA) on July 31, 2025, for the supply of Veozah 45 mg tablets (30-count packaging). The contract carries a firm fixed price structure with no set-aside designation, indicating competitive award. The pharmaceutical product will be performed at the contractor's Conshohocken facility, with an ultimate completion date of August 1, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,575.22 to AmerisourceBergen Drug Corp for VEOZAH 45 mg tablets (30-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed price delivery order was competitively awarded without set-aside provisions and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $2,432.43 to AmerisourceBergen Drug Corp for Veozah 45 mg tablets (30-count packaging) on August 19, 2025, with an ultimate completion date of August 20, 2025. This firm fixed-price delivery order represents a competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office...
- The Defense Logistics Agency awarded a $2,768.73 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count) on September 5, 2025, with an ultimate completion date of September 8, 2025. The contract is non-set-aside and competitively awarded, with performance to be completed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $2,489.95 to AmerisourceBergen Drug Corp for VEOZAH 45 mg tablets (30-count units) on August 4, 2025, with an ultimate completion date of August 5, 2025. This firm fixed price delivery order carries no set-aside designation and represents a competitively awarded transaction under the company's broader pharmaceutical supply agreement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $16,183.30 to AmerisourceBergen Drug Corp for the supply of Veozah 45 mg tablets (30-count units). The award was made on September 8, 2025, with an ultimate completion date of September 9, 2025, under firm fixed price terms with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's existing Indefinite Delivery...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWHHZDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,339.66 to AmerisourceBergen Drug Corp for VEOZAH 45 mg tablets (30-count packaging) on May 6, 2025, with an ultimate completion date of May 7, 2025. This firm fixed-price delivery order represents a non-competitive award made under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026. The contract is being performed at AmerisourceBergen's corporate headquarters location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement, supplying a comprehensive range of pharmaceuticals and medical supplies to military and veteran healthcare systems. This delivery order for VEOZAH—a prescription medication—exemplifies the company's role in fulfilling specialized pharmaceutical needs across the Defense Health Agency and broader military healthcare networks. AmerisourceBergen's extensive portfolio of federal contracts demonstrates its capability to manage both high-volume commodity pharmaceuticals and specialized medications across multiple therapeutic domains through firm fixed-price delivery arrangements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 5/6/25 |